Literature DB >> 7779533

Concentration and distribution of tumor associated antigens TAG-72 and CEA in stomach cancer.

J K Chung1, M C Lee, H K Chung, S M Lim, J J Jang, C S Koh.   

Abstract

We measured the concentration and distribution of tumor associated antigens, TAG-72 and CEA, in stomach cancer by in vitro quantitative autoradiography (IV-QAR). Frozen sections of 33 specimens were incubated with varying concentrations of 125I-labeled CEA-79.1 and B72.3 antibodies specific for carcinoembryonic antigen (CEA) and tumor-associated glycoprotein-72 (TAG-72), respectively. Computer analysis of specific antibody binding gave maximal binding values which were equal to the concentrations of the antigen or epitope. TAG-72 was detected in 25 specimens, at a concentration ranging from 8.4 to 562.9 pmol/g. CEA was detected in 32 of the 33 specimens and its concentration ranged from 8.8 to 525.3 pmol/g. The distribution of TAG-72 by IV-QAR coincided with that of the tumor cells in 41.4% of the pathologic lesions. The distribution of CEA coincided with the tumor cells in 80.5% of pathologic lesions, nearly twice the TAG-72. The concentration of TAG-72 was significantly higher in mucinous adenocarcinoma and mucin containing adenocarcinomas than other types of adenocarcinomas. There was no significant difference in the concentration of CEA among the pathologic types of stomach cancer. In summary, stomach cancer exhibited wide variations in TAG-72 and CEA expression. CEA expression was more frequent and homogeneous than TAG-72.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779533     DOI: 10.1007/bf03165002

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  25 in total

1.  Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.

Authors:  N Ohuchi; J F Simpson; D Colcher; J Schlom
Journal:  Int J Cancer       Date:  1987-12-15       Impact factor: 7.396

Review 2.  Radioimmunodetection and radioimmunotherapy.

Authors:  S M Larson; J A Carrasquillo; J C Reynolds
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

3.  Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.

Authors:  A A Epenetos; K E Britton; S Mather; J Shepherd; M Granowska; J Taylor-Papadimitriou; C C Nimmon; H Durbin; L R Hawkins; J S Malpas; W F Bodmer
Journal:  Lancet       Date:  1982-11-06       Impact factor: 79.321

4.  Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.

Authors:  J M Esteban; D Colcher; P Sugarbaker; J A Carrasquillo; G Bryant; A Thor; J C Reynolds; S M Larson; J Schlom
Journal:  Int J Cancer       Date:  1987-01-15       Impact factor: 7.396

5.  Gastric carcinoma. A ten-year review.

Authors:  J T Diehl; R E Hermann; A M Cooperman; S O Hoerr
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

6.  Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning.

Authors:  D M Goldenberg; F DeLand; E Kim; S Bennett; F J Primus; J R van Nagell; N Estes; P DeSimone; P Rayburn
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

7.  Radioimmunoscintigraphy of advanced gastrointestinal carcinomas employing I-131 labeled CEA-79 monoclonal antibody.

Authors:  J K Chung; C W Choi; M C Lee; H K Chung; N K Kim; K W Choi; C S Koh
Journal:  Ann Nucl Med       Date:  1993-05       Impact factor: 2.668

8.  Carcino-embryonic antigen (CEA) in gastric adenocarcinomas. Morphologic patterns and their relationship to a histogenetic classification.

Authors:  K Nielsen; P S Teglbjaerg
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1982-11

9.  Simultaneous measurement of blood flow and glucose metabolism by autoradiographic techniques.

Authors:  G Mies; I Niebuhr; K A Hossmann
Journal:  Stroke       Date:  1981 Sep-Oct       Impact factor: 7.914

10.  Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.

Authors:  D Colcher; A M Keenan; S M Larson; J Schlom
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.